Table 2. Baseline demographics, clinical characteristics, and CACS of LCSCT vs. ACCT populations.
| LCSCT (n = 66) |
ACCT (n = 40) |
P Value | |
|---|---|---|---|
| Age, years, median (IQR) | 65 (58, 67) | 65 (59, 67) | 0.919 |
| BMI, median (IQR) | 31 (26, 35) | 31 (27, 34) | 0.987 |
| Male, n (%) | 61 (92) | 37 (93) | 0.715 |
| Caucasian, n (%) | 57 (86) | 34 (85) | 0.927 |
| African American, n (%) | 9 (14) | 6 (15) | 0.927 |
| DM, n (%) | 19 (29) | 12 (30) | 0.931 |
| Hypertension, n (%) | 49 (74) | 29 (73) | 0.976 |
| Hyperlipidemia, n (%) | 43 (65) | 31 (78) | 0.261 |
| Total Cholesterol, median (IQR) | 169 (145, 201) | 171 (147, 204) | 0.825 |
| HDL Cholesterol, median (IQR) | 36 (36, 55) | 41 (36, 54) | 0.759 |
| Statin Use, n (%) | 39 (59) | 29 (73) | 0.235 |
| Smoking, n (%) | 51 (77) | 29 (73) | 0.748 |
| Family History of Early CAD, n (%) | 20 (30) | 16 (40) | 0.487 |
| CAD, n (%) | 10 (15) | 9 (23) | 0.487 |
| MI, n (%) | 1 (2) | 1 (3) | 0.708 |
| Prior PCI or CABG, n (%) | 0 (0) | 0(0) | N/A |
| Framingham Risk, median (IQR) | 16 (12, 19) | 16 (13, 18) | 0.809 |
| ASCVD Risk, median (IQR) | 22 (15, 28) | 21 (16, 28) | 0.868 |
| CCT CACS, median (IQR) | 160 (14, 441) | 176 (18, 500) | 0.731 |
BMI = body mass index; DM = diabetes mellitus; CAD = coronary artery disease; MI = myocardial infarction; PCI = percutaneous intervention; CABG = coronary artery bypass graft surgery; ASCVD = atherosclerotic cardiovascular disease; CT = computed tomography; CACS = coronary artery calcium score; AC = attenuation correction